Nexentis Says MitoCareX Bio Expands Computational Biology Capabilities
Nexentis said MitoCareX is expanding its internal bioinformatics expertise to broaden disease-biology analysis in its computational drug-discovery activities.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.